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Abstract
Background: Identification of pathogen DNA from archaeological human remains is a powerful tool in demonstrating that
the infectious disease existed in the past. However, it is very difficult to detect trace amounts of DNA remnants attached to
the human skeleton, especially from those buried in a humid atmosphere with a relatively high environmental temperature
such as in Asia.
Methodology/Principal Findings: Here we demonstrate Mycobacterium leprae DNA from archaeological skeletal remains in
Japan by polymerase chain reaction, DNA sequencing and single nucleotide polymorphism (SNP) analysis. In addition, we
have established a highly sensitive method of detecting DNA using a combination of whole genome amplification and
polymerase chain reaction, or WGA-PCR, which provides superior sensitivity and specificity in detecting DNA from trace
amounts of skeletal materials.
Conclusion/Significance: We have detected M. leprae DNA in archaeological skeletal remains for the first time in the Far
East. Its SNP genotype corresponded to type 1; the first detected case worldwide of ancient M. leprae DNA. We also
developed a highly sensitive method to detect ancient DNA by utilizing whole genome amplification.
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Introduction
Leprosy is a chronic infectious disease caused by Mycobacterium
leprae (M. leprae) and has affected humans for millennia. Whole
genome sequence analysis of M. leprae has revealed that the
genome is 3.3 Mbp in size, with only 1,605 genes that encode
proteins and 1,115 pseudogenes [1]. Trough comparative genome
analysis of M. leprae strains from Brazil, India, Thailand and
United States, remarkably little genomic diversity has been
uncovered suggesting that leprosy has a single clonal origin
[2,3]. Phylogeographic analysis of single nucleotide polymor-
phisms (SNPs) has revealed that M. leprae originated in Africa and
spread to European and Asian countries and then worldwide along
with human migrations and trade routes. Such geographic and
temporal migration has also been demonstrated by SNPs analysis
of ancient M. leprae DNA present in skeletal remains as old as
1,500 years ago [2,3].
Leprosy results in multiple deformities including progressive
bone defects secondary to the peripheral neuropathy caused by M.
leprae infection [4,5]. Additionally, in advanced cases M. leprae
infection causes specific osteological deformations in the areas of
the nasal aperture, anterior nasal spine and alveolar process on the
premaxilla, cortical areas of the tibia and fibula, distal ends of the
metatarsals and diaphyses of the phalanges that may include both
direct and reactive changes [6,7,8,9,10]. Paleopathological
diagnosis of leprosy has been made solely based on these
macroscopic changes in skeletal remnants. However, it is
occasionally difficult to make a definitive paleopathological
diagnosis of leprosy solely based on osseous lesions, because
syphilis, tuberculosis and other infectious and granulomatous
diseases as well as carcinomas of nasal or oral origin will cause
rhinomaxillary lesions similar to leprosy.
Direct detection of DNA remnants of pathogenic microorgan-
isms from ancient human skeletons using polymerase chain
reaction (PCR) is becoming a powerful molecular tool for clearly
demonstrating the presence of pathogens within the skeletal
remains [11]. This method provides an inestimable tool for
investigating the temporal and geographical spread of infectious
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interest in diagnosing infectious diseases in ancient remains. By the
use of so-called palaeomicrobiology, it may be possible to elucidate
the epidemiology of past infectious disease by reconstituting the
distribution of infected individuals, which is especially important in
the field of emergence and re-emergence of infectious diseases
[11]. Moreover, it may also be possible to track the genetic
evolution of the pathogenic microorganisms.
A study employing paleomicrobiology was first reported in
1993, demonstrating the presence of Mycobacterium tuberculosis (M.
tuberculosis) DNA using PCR from an ancient human skeleton [12].
Detection of M. leprae DNA was reported the next year [13] from
ancient bone dating from 600 AD, followed closely by several
other reports [14,15,16,17,18,19,20,21]. However, all of these
studies used European and Middle Eastern archaeological
materials from countries such as England, Germany, Denmark,
Poland, Hungary, Czech, Croatia, Turkey, Israel and Egypt, but
not from the Far East Asian countries. This may be related to the
superior preservation of ancient buried skeletons in these countries
compared to that in more a humid atmosphere with a relatively
high environmental temperature, such as is commonly found in
Asia [22].
Recently, we have obtained permission to examine skeletal
remains excavated in Japan with paleopathological evidence of
leprosy In the present study, we demonstrate M. leprae DNA and
SNPs from skeletal remains. We also describe a highly sensitive
whole genome amplification (WGA)-PCR method that may be
suitable for detecting trace amounts of ancient microbial DNA.
Figure 1. Geographical representation of excavation site. Location of Hatanai site in northeastern Japan (A). A map of seven cemeteries and
the site where SK26 was excavated (B). A grave pit of SK26 at excavated (C) Cemetery 5 (not shown in this map) locates 50 m south of cemetery 2. All
these figures were modified with permission from reference [23].
doi:10.1371/journal.pone.0012422.g001
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Archaeological background and osteological description
The materials used in this study were archaeological skeletal
remains excavated from the Hatanai site (N40u229, E141u299)i n
Aomori prefecture, in the northeastern part of Honshu Island in
Japan (Fig. 1A). The Hatanai site consists of several strata including
artifacts and remnants from the prehistoric Initial-Middle Jomon
(ca. 8000-4500 BP) to pre-modern Edo period (1603–1867). All
skeletal materials are stored in the Tohoku University Museum,
Sendai, Japan.
The present material (Grave No. SK26) was buried at a gravel
pit of an Edo-period cemetery in a farm village, in which was
found about 50 human skeletal remains (Fig. 1B). This corpse was
lying on its left side and hunching its back, with the elbow, hip and
knee joints closely flexed inside the burial pit (Fig. 1C). It is not
clear whether or not SK26 was placed in a wooden coffin. The
SK26 skeleton had only one Kouki-tsuhou (Kangxi-tongbao), a metallic
currency used during the rule of the Emperor Kangxi (reign in
1661–1722) of the Qing dynasty (1616–1912) in China, as grave
goods. Accordingly, the age of this burial is estimated as the
middle 18th to the early 19th century, as supposed by evidences
from other graves [23].
SK26’s skull was almost perfectly intact except for part of the
cranial base and parietal bones (Fig. 2). Although its main long
bones were intact, many of their epiphyses and all the hand/foot
bones were missing within the burial matrix of the postmortem
environment. The sex of this skeleton was assessed as male on the
basis of cranial morphologies, such as anterior decline of the
frontal bone, projection of the superciliary ridge, inferior
prominence of the mastoids, and developments of the superior
nuchal line and the external occipital protuberance. But its
bilateral pelvis was incompletely preserved and therefore unavail-
able for sex and age determination.
The age at death was estimated from dental attrition and fusions
of the cranial sutures. Surviving permanent teeth were worn to
dentine, including the 3rd molar. In the calvarium, the unions of
all sutures in the internal table were finished; coronal and
lambdoid sutures of the external table had incomplete fusing.
These dental and skeletal evidences suggest that of the age of
death, SK26 was middle-aged, in the range of 30–50 years old.
Palaeopathological observations and diagnosis
The facial cranium of SK26 showed several typical symptoms of
leprosy, suggestive of lepromatous type. In the rhinomaxillary area,
rounding deformation and abnormal enlargement of the nasal
aperture, disappearance of the anterior nasal spine, and severe
atrophy of the alveolar process were clearly observed (Fig. 2). The
palatal process showed degenerative changes, and alveolar bones at
the anterior teeth were closed by antemortem loss of all upper
incisors and the right canine.The incisor foramen inthe hard palate
had also disappeared due to osseous resorption; for maxillary
atrophy, the vertical thickness of the palatal bone was about nine
millimeters on the right side of the alveolar process, and at the same
portion on the left, only six millimeters at the maximum value.
These features of craniofacial malformation, especially the
rhinomaxillary syndrome, are specific to lepromatous leprosy but
essentially distinct from other facial-deforming diseases such as
craniofacial tuberculosis and syphilis, a treponematoses [7,8].
Although the nasal, maxillary and palatal lesions in craniofacial
tuberculosis closely resemble those in lepromatous leprosy, cranial
involvements oftuberculosis areextremelyrare inadultpatients and
mainly appear in young children, often with lesions of the mandible.
In tertiary syphilis, rhinomaxillary deformations accompany several
osteo-periostitic lesions and focal destructive remodeling (caries
sicca) caused by the bone gummas in the cranial vault [7,8]. From
differences in these pathological features, the facial deformities of
SK26 were diagnosed as leprous symptoms.
In the bilateral tibiae and fibulae of this skeleton, slight periostitic
changes were seen on the cortical surfaces of the diaphyses. The
SK26 skeleton had lost its hand and foot bones from the long-term
burial conditions, making it impossible to confirm any pencil-
shaped recessions in the distal ends of the metacarpals, metatarsals
or phalanges, which are typical leprous lesions.
Sampling of skeletal remains
Sampling was performed at the Tohoku University Museum,
where no other leprous materials were stored. Skeletal samples
were taken from the affected area as summarized in Table 1
using a small-sized rotating electric saw (Mini router, Kiso
Power Tool, Osaka, Japan). Two samples were also taken from
another skeleton (SK20; middle-aged male) found in the same
cemetery, which had no leprous changes as a negative control
for DNA purification and PCR analysis. One premolar root was
extracted from another skeleton (SK16; middle-aged female) as a
positive control for human DNA recovery. Sterile materials were
used for the sampling to avoid possible contamination. Ethical
Figure 2. Macroscopic view of the skeletal lesion in the skull of
sample SK26. Frontal view (A) and left side view (B) of the skull. Closer
view of the nasal aperture and maxillary palate (C) and upward view of
the palate (D). Arrows in panel C indicate erosive deformity of the nasal
aperture and disappearance of the anterior nasal spine. Arrowheads in
panels C and D indicate severe atrophy of alveolar bone in the maxilla/
palatal process with loss of anterior teeth. An arrow in panel D denotes
the locus of sample No. 1 shown in Table 1 and Figure 2.
doi:10.1371/journal.pone.0012422.g002
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Gene name Synonym
a) Forward (59-39) Reverse (59-39) Length (bp)
Nested primer
hsp-70, 1st ML2496 gggctgtccaaggaagag cgtcaaccacatcgtcagtag 391
(dnaK) 2nd tcgtcaaggaacaacggg cgtcaaccacatcgtcagtaga 261
16S rRNA, 1st MLP000016 agagtttgatcctggctcag tgcacacaggccacaaggga 1039
(rrs) 2nd cggaaaggtctctaaaaaatctt catcctgcaccgcaaaaagctt 171
SNP1, 1st 14,676 atttccaggtcttgtgcg aggtcttcccaggacacc 351
2nd aatggaatgctggtgagagc caatgcatgctagccttaatga 194
SNP2, 1st 1,642,875 ttagtcaacatcgttagcagccc actcataagcacggtgtctttgc 403
2nd tgctagtttaaccgagtactgcta gtagtagtcttccaagttgtggtg 189
SNP3, 1st 2,935,685 cgagcataatcgtaggcg aaatgtggtcacctgggc 510
2nd atctggtccgggtaggaatc accggtgagcgcactaag 180
Gene
cspA ML0198 gaactgtgaagtggttcaacg agcgaactccagtggcttg 186
hisE ML1309 gaccttcgaggatctgttcg atagacgtcatcgagcgaca 247
purM ML2205 aaactcacgtccgtaccttc agcacggtcagtatcttcag 233
cpsA ML2247 ggcaccttcaccaacctaga ccaacttaggatccgcttga 511
Pseudogene
pseudo scoB ML0434 tggaacacctcgtcgtatgtgg tataagtggcaccgccgaactc 201
pseudo speE ML0476 tcgcaacttcactgatcgtc gtctggcaccaataccgagt 465
pseudo REP ML0794 aaagacggagactacgatg gtttagaaggttggtcgttg 191
pseudo ahpD ML2043 tcaacatggcgatctgcattc tgcgtgaccttacaacgct 200
Non-coding region
348,457 tggactcgatgttgaagtg tgcttagctatgcagtgag 202
1,593,211 catcgagtccaagctcaac tgccgatgattacatcatcc 191
2,134,972 cggaatcctgttgacgtgtt cggcgctaacaactatcctc 242
2,152,288 ccgatatgttcggtagtcgt gcatcgatatcgccttcag 241
2,307,322 ggttcaccggaagagttgg cgcgacgactaagccagtag 242
2,546,884 tcaatatggcttcctatgttgc gctgcattaatccatgattcg 202
2,551,060 acattcgagaccagctaccg ttccgcttggaggataattg 194
2,664,658 tgagcttgccgattacgatt gccattgaactggccatc 227
2,858,681 atgttggttgagcttggac ttgcttagctatgcagtgag 217
Numbers in SNP nested primer indicate the coordinate location of the SNP. Numbers in non-coding regions indicate coordinate position of the primer within M. leprae
genome (http://genolist.pasteur.fr/Leproma/).
doi:10.1371/journal.pone.0012422.t002
Table 1. Skeletal samples.
No. Material reference Sampling site Paleopathological evidence Sample weight (mg)
1 SK26 Maxillary palate, right Erosion/atrophy 9.7
2 SK26 Inner surface of nasal cavity, right Erosion/atrophy 6.0
3 SK26 Maxillary palate, left Erosion/atrophy 4.6
4 SK26 Fibular diaphysis, right Periostitis 22.1
5 SK20 Maxillary palate, right N.R. 4.5
6 SK20 Inner surface of nasal cavity, right N.R. 6.8
7 SK16 Lower 1st premolar root, right N.R. 3.4
N.R.: No remarkable change.
doi:10.1371/journal.pone.0012422.t001
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board at National Institute of Infectious Diseases, Japan. A
permission to obtain the sample materials was granted by
Tohoku University.
DNA preparations
DNA was purified using a QIAamp DNA Micro Kit (Qiagen,
Valencia, CA) according to the manufacturer’s protocol with
some modification. Briefly, 500 ml of Buffer ATL was added to
the skeletal samples placed in a 2 ml test tube. The tube was then
filled with 1.0 mm diameter Zicronia beads (Bio Space Products,
Inc, South Lancaster, MA) and homogenized using Micro Smash
MS-100 (TOMY, Tokyo, Japan) at 3,000 rpm for 5 min at 4uC
[24,25]. Samples were then frozen at 280uC, thawed at 37uC
and homogenized for five times. The supernatant was subse-
quently treated with 40 ml of Proteinase K (20 mg/ml) and
incubated overnight at 56uC. The samples were frozen and
thawed, vortexed in 400 ml of Buffer AL then 400 ml of ethanol
was added and incubated for 5 min. Then the mixture was
applied to a QIAamp MinElute column and centrifuged at
6,0006 g for 1 min at room temperature. Flow-through was
discarded and the column was subsequently washed and DNA
was eluted by adding 20 ml of Buffer AE and centrifugation at
20,0006g for 1 min.
Polymerase chain reaction (PCR) and DNA sequencing
Touchdown PCR was performed using a PCR Thermal Cycler
DICE (TaKaRa, Kyoto, Japan) as described previously [26]. PCR
primers were designed to be specific to the M. leprae genome and
were used in previous studies [24,27,28]; all the primers are listed
in Table 2. The PCR products were analyzed by 2% agarose gel
electrophoresis. Nested PCR was used to amplify hsp-70, 16S rRNA
and SNPs. Some of the results were confirmed in an independent
laboratory.
The DNA sequence was analyzed using an ABI PRISM 310
Genetic Analyzer and GeneScan Collection software (Applied
Biosystems).
Whole genome amplification (WGA)
A GenomePlex Whole Genome Amplification kit (Sigma, St
Louis, MO) was used to amplify genomic DNA samples according
to the manufacturer’s protocol [29]. Briefly, 1 mlo f1 0 6
Fragmentation Buffer was mixed with 10 ml of DNA solution
and incubated for 4 min at 95uC. After cool down, 2 mlo f1 6
Library Preparation Buffer and 1 ml of Library Stabilization
Solution were added and incubated for 2 min at 95uC. Then 1 ml
of 16 Library Preparation Enzyme was added and incubated at
16uC for 20 min, at 24uC for 20 min, at 37uC for 20 min and at
75uC for 5 min to ensure library preparation. To amplify genomic
DNA, 7.5 mlo f1 0 6 Amplification Master Mix, 47.5 mlo f
Nuclease-free Water and 5 ml of Jumpstart Taq DNA polymerase
were added and heated at 95uC for 3 min, then 14 cycles of two-
temperature amplification was employed at 94uC for 15 sec and
65uC for 5 min using a PCR Thermal Cycler DICE (TaKaRa).
The quality of the WGA products was evaluated by 1% agarose
gel electrophoresis.
Others
All experiments were performed in a biosafety level 2 (BSL2)
laboratory where samples were handled in a safety cabinet using
disposable sterile materials to avoid any contamination.
Results
Demonstration of M. leprae DNA by PCR and DNA
sequencing
The purified DNA from seven different sites of skeletons from
three individuals was subjected to PCR amplification of the M.
leprae-specific hsp-70 gene and 16S rRNA genes. A nested PCR
protocol to amplify the M. leprae-specific 16S rRNA region was
developed in our laboratory. Among four samples taken from
Figure 4. Sequence analysis of the three reported SNPs of M. leprae DNA. Each locus was PCR amplified and sequenced as described in the
Materials and Methods.
doi:10.1371/journal.pone.0012422.g004
Figure 3. PCR detection of M. leprae DNA from skeletal samples.
PCR analysis was performed using M. leprae-specific hsp-70 and 16S-
rRNA primers for the DNA samples listed in Table 1. PCR products were
evaluated by 2% agarose gel electrophoresis. Human b-globin gene was
also PCR amplified as a control for DNA preparation from a premolar
root. NC1: a negative control for DNA purification in which DNase/
RNase-free water was used as a sample for DNA extraction; NC2: a
negative control for PCR in which DNase/RNase-free water was used
instead of a DNA sample for PCR reaction; and PC: positive control DNA
from Thai 53 strain of M. leprae.
doi:10.1371/journal.pone.0012422.g003
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No. 1 (right maxillary palate of SK26) and No. 4 (right fibula of
SK26), but not from the others (Fig. 3). Samples taken from control
bones wereallnegative. Humanb-globinDNAwas detected by PCR
only from sample No. 7 (lower premolar root of SK16).
The specificity of these PCR amplifications was confirmed by
DNA sequencing of the PCR products purified from agarose gel.
Basic Local Alignment Search Tool (BLAST) search of the DNA
sequence was a 100% match with the reported M. leprae sequence
for both hsp-70 and 16S rRNA as expected (data not shown). The
results clearly confirmed that M. leprae was involved in the skeletal
lesions of SK26 diagnosed as lepromatous leprosy.
SNP analysis of the M. leprae DNA
To determine the possible origin of the M. leprae found in this
skeleton, we analyzed single-nucleotide polymorphisms (SNPs) at 3
reported loci in the M. leprae genome [2,3]. PCR amplification
followed by direct sequencing identified the sequence at the 3 loci.
Positions 14,676, 1,642,875 and 2,935,685, were ‘‘C’’, ‘‘G’’ and
‘‘A’’, respectively (Fig. 4). This genotype of M. leprae DNA is
reported as SNP type 1, which is the dominant type in India and
Southeast Asia [2,3].
Evaluation of WGA-PCR method
We have attempted to amplify other regions of the M. leprae
genome using PCR primers we have designed previously [27] and
found that the sensitivity to detect M. leprae DNA from ancient
samples is significantly lower than from the clinical samples we
analyze in our laboratory. To solve this problem, we have applied
WGA to amplify whole genomic DNA purified from skeletal
samples. Purified DNA from sample No. 1 was subjected to WGA
and the DNA before and after WGA was compared by PCR using
19 different PCR primers targeting open reading frames,
pseudogenes and non-coding regions of the M. leprae genome
[24,27]. WGA-amplified DNA was positive for 15 sets of PCR
primers, while M. leprae genomic DNA was detected by only 7
primer sets in the original DNA sample (Fig. 5), showing that
WGA-PCR has superior sensitivity over conventional PCR.
Discussion
We have demonstrated M. leprae DNA in excavated human
skeletal remnants from Japan by both PCR analysis and DNA
sequencing. We also sequenced three SNPs in the M. leprae DNA
and confirmed that the bacilli are of the dominant type in
Southeast Asia. Although M. leprae DNA has already been found in
archaeological bone remains in Europe and the Middle East
[13,14,15,16,17,18,19,20,21], there have been no reports from Far
East Asia. This may be related to the geographical and
environmental diversity between Europe and Asia, where
archaeologists and anthropologists have not paid much attention
to palaeopathological topics of leprosy and other infectious
diseases [22]; Asia’s predominantly hot and humid climate may
cause difficulty in recovering skeletons buried for several hundred
years.
The present case was excavated in the northern part of Japan
and showed typical osteological changes of leprosy. We took
skeletal samples from four different areas, the inner surface of the
nasal cavity, maxillary palate and diaphysis of the fibula, that
showed deformities by erosion and atrophy, or mild periostitis. M.
leprae DNA was successfully demonstrated in the maxillary palate
and fibular diaphysis.
Although subperiostal exostoses and/or hypertrophy accompa-
nied by swelling or porotic hyperosteosis of the fibula are reported
as the typical signs of leprosy [6,7], the presence of M. leprae DNA
in the fibula was somewhat surprising to us because apparent
fibular lesion is not common in leprosy patients at present. It is
well known that the common fibular nerve is one of the sites
preferably affected by M. leprae, which causes foot drop in the
patient [30]. It may therefore be possible to speculate that M. leprae
affected the periosteum through this nerve. If that is the case, the
present identification of M. leprae DNA in the fibula supports the
possibility that M. leprae can spread significantly throughout the
body when patients are left untreated.
Figure 5. Comparison of conventional PCR and WGA-PCR. PCR
was performed using a DNA sample derived from the present study
(sample No. 1 shown in Table 1 and Fig. 3). The DNA before and after
WGA (‘‘2’’ and ‘‘+’’, respectively) was amplified using specific nested
primers and direct primers targeted for the genes, pseudogenes and
non-coding regions of M. leprae genome as listed in Table 2. Names of
the genes and pseudogenes are indicated and the coordinate positions
of non-coding regions in the genome (http://genolist.pasteur.fr/
Leproma/) are indicated numerically. PC: positive control DNA from
Thai 53 strain of M. leprae; and NC: negative control using DNase/RNase-
free water instead of a DNA sample for PCR reaction.
doi:10.1371/journal.pone.0012422.g005
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1, which is a major group in Southeast Asia and India, but rather
minor in modern East Asia including Japan and China [2,3]. All
reported SNP types of ancient M. leprae DNA from Europe and
Middle East are type 3, which is also a major genotype in the same
regions at present [3]. However, this study confirmed the first case
of SNP type 1 as ancient DNA samples. Although more evidence is
required, this suggests the possibility that in the Far East inclusive
of Japan, the dispersal process of the phylogenetic type of leprosy is
historically different from the occidental world. In the Southeast
Asia and India where the modern dominant SNP group is type 1,
archaeological skeletal remains with lesions of lepromatous leprosy
have been excavated and dated from ca. 2000 BC (India) to ca.
300 BC-500 AD (Thailand) [31,32]; therefore the type 1 genotype
in modern Japan might be traced back to Southeast Asia and
probably originated in India. A historical record of ancient Japan
mentioned that the oldest case suggestive of leprosy dated back to
the 7
th century, and the oldest positive palaeopathological
evidence at present is dated to the 13
th century. The genotypes
of these ancient and medieval materials are still unknown, and
further examination of ancient materials from Eastern and
Southeast Asia are needed in order to determine the dispersal
history of leprosy in Far East Asia.
In our laboratory, PCR detection of M. leprae DNA is routinely
performed from small amounts of clinical samples of skin smears
or paraffin sections as part of a government reference center. It is
difficult, however, to apply the same PCR protocol to detect M.
leprae from ancient DNA recovered from skeletal remains. To
overcome this problem, we have utilized WGA, a technique that
enables amplification of minute amounts of DNA [29], to increase
the sensitivity for PCR detection. We have successfully utilized this
method to amplify and detect environmental bacteria from small
amounts of water taken from the sea or lakes in Japan
(unpublished data).
By PCR reaction using WGA-amplified DNA (WGA-PCR
method), large amounts of DNA could be generated from minute
amounts of original DNA samples and the detection rate of M.
leprae DNA and signal intensity were significantly improved. Thus,
this method enables highly sensitive detection of small amounts of
clinical, environmental and ancient DNA. On the other hand, it
also carries the risk of contamination and false positives,
particularly if performed by an individual lacking appropriate
knowledge and training in molecular biology. Even using this
method, however, some primers still did not work on ancient
DNA. This might be due to DNA fragmentation in the ancient
sample and/or because of the DNA fragmentation process
employed during the library preparation step in the WGA
protocol. In general, genomic DNA from dead organisms
gradually degrades into short fragments over time mainly due to
the activity of nucleases produced by microorganisms in the soil.
PCR detection, even using the present WGA-PCR method, will be
difficult to perform when such a fragmentation proceeds,
especially for very old materials and those buried in conditions
where the decomposition process is accelerated, e.g. a hot and
humid environment. Nevertheless, WGA-PCR seems to be
advantageous for improving the sensitivity of DNA recovery from
these samples. We are now routinely utilizing this method to detect
ancient DNA and believe that it will be applicable for detecting
other kinds of DNA from archaeological samples, as well as other
kinds of samples with trace amounts of DNA.
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